Background: The overall risk of cancer following ileal pouch-anal anastomosis [IPAA] is unknown, and pouch cancer surveillance is controversial. We evaluated long-term risk of cancer in a national cohort of patients with ulcerative colitis and IPAA, with emphasis on pouch cancer. Methods: Data on incident cancers were extracted from the national Danish Cancer Registry. Incidence rates for all site-specific cancers were compared between patients with IPAA and a gender-and age-matched comparison cohort from the background population to obtain incidence rate ratios [IRRs]. Results: A total of 1723 patients with IPAA, operated for ulcerative colitis in the period 1980-2010, were matched to 8615 individuals from the background population. During a median follow-up of 12.9 years (interquartile range [IQR] 7.7-19.6 years), two pouch cancers [0.12%] were found after 16 and 27 years, respectively. In the population comparison cohort, 38 intestinal cancers [0.45%] were found, of which 35 were colorectal. The risk of hepatobiliary cancer was higher for patients with IPAA {IRR = 13.0 (95% confidence interval [CI]: 3.1-76.1)}, and half of the affected patients had coexisting primary sclerosing cholangitis. The risk of cancer overall following IPAA was identical to that of the comparison cohort: IRR = 1. 05 [0.84-1.31]. Conclusions: Pouch cancer following IPAA is very rare, questioning the need for general, rather than selective, surveillance. The overall cancer risk is comparable to that of the background population, and the increased risk of hepatobiliary cancer is likely an effect of coexisting liver disease and not causally related to IPAA.
Introduction
Patients with ulcerative colitis [UC] are at an increased risk of developing colorectal cancer. 1 Accordingly, excision of the colon and rectum should abolish this risk.
Restoration of bowel continuity with an ileal pouch-anal anastomosis [IPAA] is preferred by most patients, but with the procedure, residual mucosa is left at the anal transition zone and inadvertently the rectal cuff, even if a mucosectomy is performed. 2, 3 Patients with IPAA are therefore left with a persistent risk of cancer. An estimated risk of pouch neoplasia of up to 7% at 20 years 4 has sparked much debate on the potential benefits of cancer surveillance of patients with IPAA. [5] [6] [7] So far, most studies on the incidence of pouch cancer are based on referral centre cohorts 8, 9 and follow-up is generally short. 10 Further, the risk of cancer has not been directly contrasted to the risk seen in comparable populations, and absolute risks of pouch cancer are difficult to interpret without an appropriate reference risk for comparison.
The risk of intestinal cancer has been the primary focus of cancer research in UC and IPAA, but the risk of developing extraintestinal cancers has only been investigated in UC patients overall, where the risk of cancer is slightly higher compared with that of the general population. 11 So far, overall cancer risk following colectomy and IPAA remains an unanswered question. Exposure to the potentially carcinogenic effects of thiopurines 12 and diagnostic ionising radiation 13 may decline following IPAA and lead to a lower risk of non-melanoma skin cancer, melanoma, and lymphoproliferative malignancies, approaching that of the general population. The lower risk of smoking-related cancers found in UC populations compared with background populations 14, 15 is likely to persist or even be further reduced after IPAA, since abstinence from smoking is usually a prerequisite for undergoing major elective surgery. However, these hypotheses relating to cancer risk after IPAA have not been tested.
We therefore conducted a study on the risk of cancer in a national cohort of patients with UC and IPAA, with emphasis on the risk of pouch cancer.
Materials and Methods

Setting
This study was conducted by linking person-level data from national registries via the civil registration number of each individual from a national cohort of patients operated with IPAA and individuals from the background population matched on age and gender. Study approval was obtained from the National Danish Data Protection Agency [approval no. 1-16-02-225-16].
IPAA cohort and population-based comparison cohort
From 1980-2010, a total of 1757 patients who had primary IPAA surgery for UC were identified from a previous study. 16 We excluded 34 patients erroneously coded as having had IPAA surgery. This left 1723 patients with IPAA in the cohort. To be able to compare the risk of cancer in the IPAA cohort with that of the general population, we matched each patient with UC and IPAA to five comparators of the same age and gender distribution from the background population [ Table 1 ]. Members of this population comparison cohort were assigned an index date identical to the date of IPAA surgery for patients with UC and IPAA. Subjects from the population comparison cohort were randomly identified using data from the Civil Registration System, which is a nationwide database containing data on dates of birth and death, emigration, and residency for all persons living in Denmark. 17 Vital and emigration status for both patients and the background population was obtained from this database.
For patients with UC and IPAA, regular pouch cancer surveillance was offered only at one department, representing 9.3% [n = 160] of the UC cohort. Individuals from the background population were not screened for intestinal malignancies, as the nationwide Danish colorectal cancer screening programme for persons aged 50-74 years was first introduced in March 2014.
Outcome
Cancer diagnoses after the index IPAA date [specified in Table 1] were identified for both patients with UC and IPAA and the comparison cohort. Patients with cancer diagnoses before the index date were not excluded, as they may represent a subgroup of patients with particularly high cancer risk. 18 Data on all incident cases of cancer up to and including February 2014 were extracted from the Danish Cancer Registry. The registry contains accurate data on virtually all cancers diagnosed since 1943, and reporting of malignancies and associated dysplastic conditions to the registry has been compulsory for all Danish physicians since 1987. 19 Intestinal cancers were defined as colorectal, anal, and small bowel cancers of any histological type, although excluding squamous cell carcinomas of the anus. To define pouch cancer, hospital charts for IPAA patients with intestinal cancer were reviewed and cancers originating from the pouch or anal transition zone were defined as pouch cancers. To ensure capture of all possible pouch cancers, we also scrutinised cases in the IPAA cohort where a melanoma or lymphoma diagnosis was followed by excision of the pouch or the formation of a permanent stoma.
Covariates
The Danish National Patient Registry 20 was used to capture information on diagnoses of primary sclerosing cholangitis [ICD-8 575.04, ICD-10 K83.0F], as this condition may predispose to pouch cancer. 18 From this registry, we also identified lower endoscopy procedures [procedure codes 91060, 91065, 91070, 91080, 91090, KUJF32-85, or KUJG] following the index date, to determine differences in surveillance between the two cohorts. Information on pouch failure, ie pouch excisions or stoma formations, was available from a previous study. 
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Statistical analysis
Patients with IPAA and population comparators were followed from the index date until a relevant cancer diagnosis, death, emigration, or end of follow-up [ March 1, 2014] , whichever came first. Patients were not censored in case of pouch failure.
We calculated incidence rates [IRs] of cancers among patients with IPAA and the population comparators as the number of individuals with a relevant cancer divided by total follow-up time in each cohort. Incidence rate ratios [IRRs] were then calculated as the IR in the IPAA cohort divided by the IR in the population comparison cohort for the same cancer.
The risk of non-melanoma skin cancers was illustrated for patients with IPAA and the population comparators as cumulative incidence functions.
Results
A total of 1723 patients with IPAA were matched to 8615 individuals from the background population. The mean age at the index date was 33.1 years, and 52% were male [ No pouch or intestinal cancers were diagnosed in the 46 patients with IPAA and pre-existing primary sclerosing cholangitis, and no pouch cancers were found among the patients, who were offered regular screening endoscopies. No diagnosis of lymphoma or melanoma was followed by pouch excision or creation of a stoma.
Intestinal and pouch cancer risk
During a median follow-up of 12.9 years following the index date, two [0.12%] of 1723 patients with IPAA were diagnosed with pouch cancer [ Table 2 ], corresponding to an IR of 8.4 cases per 100 000 person-years [95% CI: 2.1-33.5]. The clinical characteristics of these two cases are detailed in Table 3 . A third patient with IPAA was diagnosed with an anal squamous cell carcinoma and was thus not included in the analysis.
In the population comparison cohort, 38 intestinal cancers were found during a median 12.5 years of observation (IR = 32.7 cases per 100 000 person-years [95% CI: 23.8-45.0]), of which 35 were colorectal and three were small bowel cancers.
Excluding colorectal cancers in the population comparison cohort revealed an IR of 2.6 cases per 100 000 person-years [95% CI: 0.8-8.0].
Other cancers
Overall cancer incidence rates for patients with UC and IPAA and subjects from the comparison cohort are summarised in Figure 1 ]. For the analysis of hematological cancers combined, and for cancers of the female reproductive organs, male reproductive organs, and urinary tract, patients with UC and IPAA had a similar risk compared with the population comparison cohort, although estimates were very imprecise. Smoking-related cancers occurred with a lower incidence rate for patients with UC and IPAA compared with the population comparison cohort (IRR = 0.70 [95% CI: 0.33-1.32]), although this estimate was also based on few cases.
Discussion
This is the first study to assess overall cancer risk following IPAA for UC in a general and unselected population, using nationwide health registries with documented high validity. We found that the overall cancer risk in the IPAA population was equivalent to the background population risk, with a higher risk of hepatobiliary cancer and non-melanoma skin cancer being counterbalanced by a lower risk of tobacco-related cancers and, obviously, intestinal cancers.
Only two pouch cancers [0.12%] were found in the IPAA cohort during a median 12.9 years of observation. Considering the very low absolute and relative risk of pouch cancer found in our study, general pouch cancer screening seems unjustified.
The low number of outcome events prevents us from subgroup analyses of individuals with a priori high risk of cancer, eg patients with primary sclerosing cholangitis, lack of mucosectomy at index IPAA, chronic pouchitis, a family history of colorectal cancer, or previous colorectal cancer or dysplasia. 4, 8, 18 The low number of patients with a previous colorectal cancer diagnosis [n = 20] , which is universally recognised as the most important risk factor for pouch cancer, 18 probably also contributes to the very low number of pouch cancers in this cohort.
Two large, population-based studies from The Netherlands 4 and the Cleveland Clinic 8 found cumulative incidences of pouch cancer of 3.3% and 2.4% at 20 years, respectively, which is in sharp contrast to our findings. However, six of the 16 pouch cancers found among 1200 Dutch patients in the former study were either colorectal cancer recurrences or found in patients with Crohn's disease. Also, both studies used Kaplan-Meier methodology to determine the cumulative risk of pouch cancer. Unfortunately, this approach may exaggerate risk estimates in the presence of competing risks [eg, death], 22 so the true risk of pouch cancer may in fact be lower than previously reported. A recent Swedish nationwide study found one case of pouch cancer in a population of 1796 patients, although the study relied solely on registry data to capture pouch cancers with no subsequent validation. 23 Further, pouch cancers in this study were defined only as cancers with rectal morphology, so some cancers may have been missed.
In the present study, patients with UC and IPAA were found to be at a higher risk of hepatobiliary carcinomas, similar to what has been found in unselected UC populations, [24] [25] [26] and half of these patients had concurrent primary sclerosing cholangitis. Whether the remaining IPAA patients had subclinical primary sclerosing cholangitis or otherwise undiagnosed liver disease is unknown, but these results emphasise the association between primary sclerosing cholangitis and hepatobiliary cancer. A previous prospective study found that total proctocolectomy had no impact on the liver biochemistry or clinical disease activity in patients with inflammatory bowel disease [IBD] and primary sclerosing cholangitis. 27 Although we did not estimate the effect of colectomy and IPAA on the risk of hepatobiliary carcinoma, we infer that the risk of hepatobiliary cancer seen in general UC populations 11 does not seem to be mitigated by excision of the colon and rectum.
The increased risk of non-melanoma skin cancers corresponds well to findings from meta-analysis of cancer risk from population-based UC studies 28 and may be a result of greater exposure to ultraviolet Table 2 . Number of site-specific cancers and incidence rates. Incidence rate ratios are calculated with the incidence rate of IPAA patients as the numerator and the incidence rate of the population comparators as the denominator. radiation in the IPAA group, although the comparable risk of melanoma argues against it. Exposure to thiopurines has been linked to an almost 6-fold increased risk of non-melanoma skin cancer in UC, 12, 29, 30 and so a residual effect of these drugs on non-melanoma skin cancer risk may persist following IPAA. However, considering a median time to non-melanoma skin cancer of 13.3 years following IPAA, it seems more plausible that the risk is an effect of detection bias with patients being in regular contact with physicians, although a genuine biological effect with 10 years' lag time from exposure before IPAA to manifest cancer cannot be excluded.
The lower risk of tobacco-related cancers is a reassuring finding, as it indicates that the low exposure to tobacco which generally characterises UC populations 14, 15 is maintained in the long term after colectomy and IPAA. However, as we did not have information on lifestyle factors, we could not confirm that tobacco use in fact is infrequent following IPAA.
In UC, immunomodulatory medicine has been implicated in the pathogenesis of haematological malignancies, especially myeloid leukaemia. 31 Unfortunately, data on potentially carcinogenic drugs were also unavailable in this study. Nonetheless, the equivalent risks of leukaemias, lymphomas, and melanomas is an encouraging finding, which indicates that discontinuation of immunomodulatory medicine following colectomy and IPAA brings the risk of these cancers to a level found in an unexposed background population.
Whereas we used valid registry data with long-term follow-up from a tax-funded universal health care service where cancer cases are very unlikely to be missed, longer follow-up is needed before conclusions on life-time risk of cancer can be drawn. Differences in demography, lifestyle, and the availability of health care services between Danish patients and patients from other countries may however impede the generalisability of the results.
In summary, the risk of cancer following IPAA is similar to that of the background population. Pouch cancers are very rare, and general screening seems irrelevant. Selective screening of patients with risk factors for pouch cancer may be feasible, but further research is needed to assess if such an approach reduces the risk of developing cancer or improves prognosis. An increased risk of hepatobiliary cancer following colectomy and IPAA is likely explained by coexisting primary sclerosing cholangitis, and therefore not causally related to proctocolectomy with IPAA. 
